BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng M, Wei W, Duan J, Chen R, Wang N, He L, Peng Y, Ma X, Wu Z, Liu J, Li Z, Zhang Z, Jiang L, Zhou F, Xie D. ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21. Cancer Sci 2021;112:1758-71. [PMID: 33440047 DOI: 10.1111/cas.14810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Lou W, Chen G, Ding B, Kuang J, Zhang Y, Wang C, Duan S, Deng Y, Lu X. Genome-wide screening for the G-protein-coupled receptor (GPCR) pathway-related therapeutic gene RGS19 (regulator of G protein signaling 19) in bladder cancer. Bioengineered 2021;12:5892-903. [PMID: 34482807 DOI: 10.1080/21655979.2021.1971035] [Reference Citation Analysis]
2 Luna-Velez MV, Dijkstra JJ, Heuschkel MA, Smit FP, van de Zande G, Smeets D, Sedelaar JPM, Vermeulen M, Verhaegh GW, Schalken JA. Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder. Mol Oncol 2021;15:1882-900. [PMID: 33797847 DOI: 10.1002/1878-0261.12957] [Reference Citation Analysis]
3 Zhang J, Zhang C, Cao P, Zheng X, Yu B, Cao H, Gao Z, Zhang F, Wu J, Cao H, Hao C, Sun Z, Wang W. A zinc finger protein gene signature enables bladder cancer treatment stratification. Aging (Albany NY) 2021;13:13023-38. [PMID: 33962398 DOI: 10.18632/aging.202984] [Reference Citation Analysis]
4 Deng M, Wei W, Duan J, Chen R, Wang N, He L, Peng Y, Ma X, Wu Z, Liu J, Li Z, Zhang Z, Jiang L, Zhou F, Xie D. ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21. Cancer Sci 2021;112:1758-71. [PMID: 33440047 DOI: 10.1111/cas.14810] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Zhu K, Liu X, Deng W, Wang G, Fu B. Identification of a chromatin regulator signature and potential candidate drugs for bladder cancer. Hereditas 2022;159. [DOI: 10.1186/s41065-021-00212-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Dong B, Liang J, Li D, Song W, Song J, Zhu M, Zhao S, Ma Y, Yang T. Identification of a Prognostic Signature Associated With the Homeobox Gene Family for Bladder Cancer. Front Mol Biosci 2021;8:688298. [PMID: 34368227 DOI: 10.3389/fmolb.2021.688298] [Reference Citation Analysis]